Screener
Inhibrx Biosciences, Inc. INBX Nonmonetary Transaction, Gain (Loss) Recognized On Transfer, Net
Nonmonetary Transaction, Gain (Loss) Recognized On Transfer, Net at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept inbx:NonmonetaryTransactionGainLossRecognizedOnTransferNet.
The source filing: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026. Open the filing →
- Filed
- Mar 19, 2026, 4:00 PM EDT
- Fiscal year
- FY2025
- Accession
- 0002007919-26-000006
FAQ
- What is Inhibrx Biosciences, Inc.'s nonmonetary transaction, gain (loss) recognized on transfer, net?
- Inhibrx Biosciences, Inc. (INBX) reported nonmonetary transaction, gain (loss) recognized on transfer, net of $0 in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s nonmonetary transaction, gain (loss) recognized on transfer, net changed year-over-year?
- Inhibrx Biosciences, Inc.'s nonmonetary transaction, gain (loss) recognized on transfer, net decreased by 100.0% year-over-year, from $499.7M to $0.
- What does nonmonetary transaction, gain (loss) recognized on transfer, net mean?
- This reflects gains or losses recognized from non-cash exchanges of assets or services, such as bartering or equity-based settlements. These transactions do not involve the direct exchange of cash and are adjusted out of operating cash flow to isolate core business performance. High volatility in this metric may indicate significant non-recurring accounting adjustments or strategic asset restructuring.
Ask your AI about Inhibrx Biosciences, Inc.'s nonmonetary transaction, gain (loss) recognized on transfer, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude